RWD supports regulatory decisions in Europe, but more sources are needed
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsEuropePharmaceuticalsProduct LifecycleRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsEuropePharmaceuticalsProduct Lifecycle